Occurrence of acute large and edematous callosal lesions in neuromyelitis optica

Multiple Sclerosis

Volumn 15, Issue 6, 2009, Pages 695-700

  Nakamura, M ^a   Misu, T ^a   Fujihara, K ^a   Miyazawa, I ^a   Nakashima, I ^a   Takahashi, T ^a,b   Watanabe, S ^a   Itoyama, Y ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yonezawa National Hospital   (Japan)

Author keywords

Callosal lesion; Corpus callosum; MRI; Multiple sclerosis; Neuromyelitis optica; NMO IgG

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; CHRONIC DISEASE; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; HUMAN; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ACUTE DISEASE; ADULT; BRAIN EDEMA; CORPUS CALLOSUM; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 66149168702     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509103301     Document Type: Article

References (35)

1. Misu, T, Fujihara, K, Nakashima, I, et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002; 125: 2460-2468.
2. de Seze, J, Stojkovic, T, Ferriby, D, et al. Devic's neuromyelitis optica: Clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002; 197: 57-61.
3. Ghezzi, A, Bergamaschi, R, Martinelli, V, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004; 251: 47-52.
4. Lucchinetti, CF, Mandler, RN, McGavern, D, et al. A role for humoral mechanism in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
5. Mandler, RN, Davis, LE, Jeffery, DR, Kornfeld, M. Devic's neuromyelitis optica: A clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-168.
6. O'Riordan, JI, Gallagher, HL, Thompson, AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382-387.
7. Wingerchuk, DM, Hogancamp, WF, O'Brien, PC, Weinshenker, BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
8. Nakashima, I, Fujihara, K, Sato, S, Itoyama, Y. Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol 2005; 159: 133-136.
9. Lennon, VA, Wingerchuk, DM, Kryzer, TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
10. Wingerchuk, DM, Lennon, VA, Pittock, SJ, Lucchinetti, CF, Weinshenker, BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
11. Nakamura, M, Miyazawa, I, Fujihara, K, et al. Preferential spinal central gray matter involvement in neuromyelitis optica: An MRI study. J Neurol 2008; 255: 163-170.
12. Dietemann, JL, Beigelman, C, Rumbach, L, et al. Multiple sclerosis and corpus callosum atrophy: Relationship of MRI findings to clinical data. Neuroradiology 1988; 30: 478-480.
13. Gean-Marton, AD, Vezina, LG, Marton, KI, et al. Abnormal corpus callosum: A sensitive and specific indicator of multiple sclerosis. Radiology 1991; 180: 215-221.
14. Friese, SA, Bitzer, M, Freudenstein, D, Voigt, K, Küker, W. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000; 42: 795-802.
15. Misu, T, Fujihara, K, Nakashima, I, Sato, S, Itoyama, Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005; 65: 1479-1482.
16. Pittock, SJ, Weinshenker, BG, Lucchinetti, CF, Wingerchuk, DM, Corboy, JR, Lennon, VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-968.
17. Poppe, AY, Lapierre, Y, Melancon, D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005; 11: 617-621.
18. Vernant, JC, Cabre, P, Smadja, D, et al. Recurrent optic neuromyelitis with endocrinopathies: A new syndrome. Neurology 1997; 48: 58-64.
19. Watanabe, S, Nakashima, I, Miyazawa, I, et al. Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. J Neurol 2007; 254: 670-671.
20. Nakashima, I, Fujihara, K, Miyazawa, I, et al. Clinical and MRI features of Japanese MS patients with NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
21. Pittock, SJ, Lennon, VA, Krecke, K, Wingerchuk, DM, Luchinetti, CF, Weinshenker, BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
22. Barkhof, F, Filippi, M, Miller, DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
23. Wingerchuk, DM, Lennon, VA, Lucchinetti, CF, Pittock, SJ, Weinshenker, BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
24. Polman, CH, Reingold, SC, Edan, G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
25. Lennon, VA, Kryzer, TJ, Pittock, SJ, Verkman, AS, Hinson, SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
26. Misu, T, Fujihara, K, Nakamura, M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: A case report. Tohoku J Exp Med 2006; 209: 269-275.
27. Misu, T, Fujihara, K, Kakita, A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
28. Roemer, SF, Parisi, JE, Lennon, VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130: 1194-1205.
29. Hinson, SR, Pittock, SJ, Lucchinetti, CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007; 69: 2221-2231.
30. Vincent, T, Saikali, P, Cayrol, R, et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol 2008; 181: 5730-5737.
31. Hinson, SR, Roemer, SF, Lucchinetti, CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008; 205: 2473-2481.
32. Kinoshita, M, Nakatsuji, Y, Moriya, M, et al. Astrocytic necrosis induced by anti-aquaporin-4 antibody-positive serum. Neuroreport (in press).
33. Badaut, J, Verbavatz, JM, Freund-Mercier, MJ, Lasbennes, F. Presence of aquaporin-4 and muscarinic receptors in astrocytes and ependymal cells in rat brain: A clue to a common function? Neurosci Lett 2000; 292: 75-78.
34. Palmer, S, Bradley, WG, Chen, DY, Patel, S. Subcallosal striations: early findings of multiple sclerosis on Sagittal, thin-section, fast FLAIR MR images. Radiology 1999; 210: 149-153.
35. Adams, CWM, Abdulla, YH, Torres, EM, Poston, RN. Periventricular lesions in multiple sclerosis: Their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurolbiol 1987; 13: 141-152.